BUDGET IMPACT ANALYSIS OF APREMILAST IN PATIENTS WITH PSORIASIS IN THE ITALIAN SETTING

被引：0
|
作者：
Barbieri, M. [1 ]
Capri, S. [2 ]
Oskar, B. [3 ]
机构：
[1] Univ York, Ctr Hlth Econ, York, N Yorkshire, England
[2] Cattaneo LIUC Univ, Sch Econ & Management, Castellanza, Italy
[3] Celgene Corp, Milan, Italy
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.560
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSS36
引用
收藏
页码：A421 / A421
页数：1
相关论文
共 50 条
  • [41] The effect of apremilast therapy on skin cytokine levels in patients with psoriasis
    Kubanov, Alexey A.
    Solomka, Viktoria S.
    Karamova, Arfenya E.
    Verbenko, Dmitry A.
    Vasileva, Elena L.
    Artamonova, Olga G.
    RUSSIAN OPEN MEDICAL JOURNAL, 2020, 9 (03)
  • [42] Four-year drug survival of apremilast in patients with psoriasis
    Kishimoto, Megumi
    Komine, Mayumi
    Kamiya, Koji
    Sugai, Junichi
    Kuwahara, Aya
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2023, 50 (07) : 960 - 963
  • [43] Synergistic cytokine effects as apremilast response predictors in patients with psoriasis
    Garcet, Sandra
    Nograles, Kristine
    da Rosa, Joel Correa
    Schafer, Peter H.
    Krueger, James G.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (03) : 1010 - 1013
  • [44] Apremilast Treatment Outcomes and Adverse Events in Psoriasis Patients With HIV
    Lauck, Kyle C.
    Nguyen, Kaycee
    Columbus, Cristie
    Tolkachjov, Stanislav N.
    CUTIS, 2024, 115 (02):
  • [45] Real-world use of apremilast for patients with psoriasis in Japan
    Kishimoto, Megumi
    Komine, Mayumi
    Hioki, Tomoyuki
    Kamiya, Koji
    Sugai, Junichi
    Ohtsuki, Mamitaro
    JOURNAL OF DERMATOLOGY, 2018, 45 (11) : 1345 - 1348
  • [46] Effectiveness of Apremilast in Real Life in Patients with Psoriasis: A Longitudinal Study
    Malara, Giovanna
    Politi, Cristina
    Trifiro, Caterina
    Verduci, Chiara
    D'Arrigo, Graziella
    Testa, Alessandra
    Tripepi, Giovanni
    ACTA DERMATO-VENEREOLOGICA, 2021, 101
  • [47] Experience with apremilast in a small cohort of patients with chronic plaque psoriasis
    Cranwell, W.
    Radulski, B.
    Dolianitis, C.
    Nicolopoulos, J.
    Varigos, G. A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 : 51 - 51
  • [48] Psoriasis in Patients With Active Lung Cancer: Is Apremilast a Safe Option?
    Apalla, Zoe
    Psarakis, Eftychios
    Lallas, Aimilios
    Koukouthaki, Alexia
    Fassas, Athanassios
    Smaragdi, Maria
    DERMATOLOGY PRACTICAL & CONCEPTUAL, 2019, 9 (04): : 300 - 301
  • [49] Budget impact analysis of apixaban versus other NOACs for the prevention of stroke in Italian atrial fibrillation patients
    Pradelli, Lorenzo
    Calandriello, Mario
    Di Virgilio, Roberto
    Bellone, Marco
    Tubaro, Marco
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2014, 15 : 5 - 14
  • [50] Analysis of Inflammatory Factors Levels and Safety in the Treatment of Psoriasis with Apremilast
    Kong, Ni
    Liu, Chong
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 232 - 236
12345